# Unlearn.AI

Segundo a telemetria do OpenAITools.app verificada em 2026-11-11, Unlearn.AI (unlearn.ai) é uma plataforma de IA indexada em Saúde com IA que gera 17,11 mil visitas mensais com variação de tráfego mês a mês de -8,23 mil (-32,5%). Seu principal mercado geográfico é Estados Unidos (69,4% de participação no tráfego) e opera com modelo de preços Preço sob consulta. As principais alternativas concorrentes por volume mensal incluem Intelligencia AI (3,87 mil visitas/mês), Cradle (16,99 mil visitas/mês), Floatz (253 visitas/mês).

Unlearn.AI builds AI-generated digital twins of clinical trial participants — forecasts of how each individual patient's outcomes would evolve — and uses them to sharpen design, interim, and readout decisions in drug development.

## Principais dados de telemetria e especificações

| Métrica | Valor |
| :--- | :--- |
| Nome da ferramenta | Unlearn.AI |
| Handle | unlearn-ai |
| Status | active |
| Origin | official |
| Maintenance | active |
| Domínio oficial | unlearn.ai |
| URL do site | https://unlearn.ai |
| Categorias | Saúde com IA, Ferramenta de pesquisa com IA, Previsões com IA, Modelos de IA, IA para análise de dados |
| Modelo de preços | Preço sob consulta |
| Visitas mensais | 17.107 |
| Variação de tráfego mensal | -8.233 |
| Taxa de crescimento mensal | -32,5% |
| Mercado principal | Estados Unidos |
| Participação de mercado | 69,4% |
| Visitas diretas | 7.493 |
| Visitas de busca orgânica | — |
| Visitas sociais | — |
| Visitas de referência | 1.401 |
| Visitas por e-mail | 653 |
| Nota de avaliação | 4,4 |
| Contagem de favoritos | 1 |
| Plataformas suportadas | Site |
| Plataformas de cobrança |  |
| Atributos | Recursos: Site; Preços: Preço sob consulta |
| Tags | IA, Gêmeos digitais, Ensaios clínicos, Pesquisa clínica, Desenvolvimento de fármacos, Saúde, Aprendizado de máquina, Análise preditiva, Simulação, Tomada de decisão baseada em dados |

## Visão geral

Unlearn.AI builds AI-generated digital twins of clinical trial participants — forecasts of how each individual patient's outcomes would evolve — and uses them to sharpen design, interim, and readout decisions in drug development.

## Preços e planos

Enterprise, contact-for-pricing model. Unlearn does not publish standard subscription tiers; engagements are scoped per study or program after a conversation with the team.

## Principais recursos e capacidades

- **AI-generated patient digital twins:** Model-based forecasts of each participant's clinical outcomes, generated from baseline data already collected, that act as a virtual comparator or as additional information per enrolled patient.
- **PROCOVA design and analysis method:** A twin-based covariate adjustment approach that Unlearn describes as EMA-qualified and FDA-supported, used to reduce sample size in randomized controlled trials while maintaining power.
- **Trial design scenario modeling:** Build and compare design scenarios — endpoints, eligibility criteria, sample size, assumptions — so governance decisions are made with quantified tradeoffs instead of positions.
- **Interim and readout analysis support:** Pre-specified twin-based analyses added to the statistical analysis plan before unblinding, plus twin-adjusted analysis delivered at interim and at readout.
- **Externally controlled study design:** Design single-arm and externally controlled studies where randomization is not an option, selecting eligibility criteria that give open-label studies the best chance of a clear readout.

## Principais casos de uso

- **Right-size a Phase 1/2 protocol before it locks (Clinical development lead):** Simulate expected enrollees against real eligibility criteria, then evaluate sample size and endpoints to lock in a smaller, lower-cost design before governance review.
- **Add pre-specified twin analyses at interim (Biostatistician):** Raise power at interim looks and in subgroup analyses without adding participants by incorporating twin-based covariate adjustment into the statistical analysis plan.
- **Recover more signal from completed trials (Program strategist):** Re-analyze finished studies with digital twins to contextualize variability, improve endpoint sensitivity, and inform whether and how the program continues.
- **Strengthen single-arm evidence (Rare-disease sponsor):** Use digital twins as the comparator in open-label or single-arm studies where randomization is impractical, tightening the evidence for regulators.

## Pontos fortes

- Digital twins are generated from data already collected, so no extra patients are required to gain information
- Publicly reported, quantified outcomes — sample-size reductions, cost savings, and enrollment time saved — rather than only qualitative claims
- Covers the whole trial lifecycle: design, interim, and readout, not just one decision point
- Named collaborations with biotech and pharma sponsors, plus regulatory-aligned methodology
- Awards and press coverage indicate an active, growing organization

## Limitações

- Pricing is not published, so budgeting requires a direct sales conversation
- The value proposition depends on regulatory acceptance of twin-based methods, which varies by agency and indication
- Best suited to sponsors with existing clinical data and statistical teams; not a self-serve tool
- Public metrics come from specific studies and may not transfer directly to other indications

## Perguntas frequentes

### Is Unlearn.AI free?
No. Unlearn.AI is an enterprise clinical-development technology company that does not publish list pricing. Engagement is scoped with the team, so cost depends on the study or program involved.

### What exactly is a digital twin?
Unlearn describes a digital twin as an AI-generated forecast of one participant's clinical outcomes. Generated from a patient's baseline data, it can serve as a virtual comparator or add information per enrolled participant.

### Which trial stages does it support?
Three: before the protocol is finalized (design), from first patient in through readout (in progress), and after readout when teams want to unlock more from data already collected.

### Does using digital twins replace real trial participants?
No. Digital twins are used alongside enrolled participants — for example, to reduce the size of a control arm or raise statistical power. They are an analytical and design aid, not a substitute for human trials.

### Who is Unlearn.AI built for?
Biopharma sponsors, clinical development and biostatistics teams, and clinical research organizations. It is a partner-led, enterprise service rather than a self-serve software product.

### Qual é o tráfego mensal e a tendência de crescimento de Unlearn.AI?
Unlearn.AI recebe atualmente 17,11 mil visitas mensais, com variação de tráfego mês a mês de -8,23 mil (taxa de crescimento de -32,5%). Seu principal mercado de origem é Estados Unidos (69,4% de participação), incluindo 7,49 mil visitas diretas/mês e — visitas de busca orgânica/mês.

### O Unlearn.AI é gratuito? Qual é o seu modelo de preços?
Unlearn.AI opera com um modelo de preços Preço sob consulta. Enterprise, contact-for-pricing model. Unlearn does not publish standard subscription tiers; engagements are scoped per study or program after a conversation with the team. As plataformas de cobrança e checkout suportadas incluem: não listado.

### Quais são as melhores alternativas de Unlearn.AI em 2026?
Com base no tráfego das categorias e na adequação de recursos do OpenAITools.app, as cinco principais alternativas a Unlearn.AI são: 1. Intelligencia AI (3,87 mil visitas/mês); 2. Cradle (16,99 mil visitas/mês); 3. Floatz (253 visitas/mês); 4. Delve AI (49,03 mil visitas/mês); 5. Dr.Oracle (723,85 mil visitas/mês).

### Quais plataformas e principais capacidades de IA o Unlearn.AI suporta?
Unlearn.AI está classificado em Saúde com IA, Ferramenta de pesquisa com IA, Previsões com IA, Modelos de IA, suporta as seguintes plataformas: Site, e suas principais tags de capacidade incluem: IA, Gêmeos digitais, Ensaios clínicos, Pesquisa clínica, Desenvolvimento de fármacos, Saúde.

## Alternativas

| Nome da ferramenta | Visitas mensais | Modelo de preços | Comparar |
| :--- | :--- | :--- | :--- |
| [Intelligencia AI](https://openaitools.app/pt/tool/intelligencia-ai) | 3.872 | Preço sob consulta | [Comparar](https://openaitools.app/pt/compare/intelligencia-ai-vs-unlearn-ai) |
| [Cradle](https://openaitools.app/pt/tool/cradle) | 16.993 | Preço sob consulta | [Comparar](https://openaitools.app/pt/compare/cradle-vs-unlearn-ai) |
| [Floatz](https://openaitools.app/pt/tool/floatz-ai) | 253 | Preço sob consulta | [Comparar](https://openaitools.app/pt/compare/floatz-ai-vs-unlearn-ai) |
| [Delve AI](https://openaitools.app/pt/tool/delve) | 49.025 | Freemium | [Comparar](https://openaitools.app/pt/compare/delve-vs-unlearn-ai) |
| [Dr.Oracle](https://openaitools.app/pt/tool/dr-oracle) | 723.847 | Teste gratuito | [Comparar](https://openaitools.app/pt/compare/dr-oracle-vs-unlearn-ai) |
| [Aitia (gnshealthcare.com)](https://openaitools.app/pt/tool/gnshealthcare-com) | 0 | Preço sob consulta | [Comparar](https://openaitools.app/pt/compare/gnshealthcare-com-vs-unlearn-ai) |
| [Upheal](https://openaitools.app/pt/tool/upheal-io) | 347.782 | Freemium, Teste gratuito, Preço sob consulta | [Comparar](https://openaitools.app/pt/compare/unlearn-ai-vs-upheal-io) |
| [Sinkove](https://openaitools.app/pt/tool/sinkove) | 86 | Preço sob consulta | [Comparar](https://openaitools.app/pt/compare/sinkove-vs-unlearn-ai) |
| [Oatmeal Health](https://openaitools.app/pt/tool/oatmeal-health) | 40.264 | Preço sob consulta | [Comparar](https://openaitools.app/pt/compare/oatmeal-health-vs-unlearn-ai) |
| [CulturePulse x Reddit](https://openaitools.app/pt/tool/culturepulse-x-reddit) | 613 | Teste gratuito, Preço sob consulta | [Comparar](https://openaitools.app/pt/compare/culturepulse-x-reddit-vs-unlearn-ai) |
| [RapidAI](https://openaitools.app/pt/tool/rapidai-com) | 20.172 | Preço sob consulta | [Comparar](https://openaitools.app/pt/compare/rapidai-com-vs-unlearn-ai) |
| [January AI](https://openaitools.app/pt/tool/january-ai) | 10.183 | Free, Contact for Pricing | [Comparar](https://openaitools.app/pt/compare/january-ai-vs-unlearn-ai) |

---
Fonte: https://openaitools.app/pt/tool/unlearn-ai